RU2016128487A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016128487A3 RU2016128487A3 RU2016128487A RU2016128487A RU2016128487A3 RU 2016128487 A3 RU2016128487 A3 RU 2016128487A3 RU 2016128487 A RU2016128487 A RU 2016128487A RU 2016128487 A RU2016128487 A RU 2016128487A RU 2016128487 A3 RU2016128487 A3 RU 2016128487A3
- Authority
- RU
- Russia
Links
Priority Applications (22)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016128487A RU2656181C1 (ru) | 2016-07-13 | 2016-07-13 | Анти-pd-1-антитела, способ их получения и способ применения |
| JOP/2019/0002A JOP20190002A1 (ar) | 2016-07-13 | 2017-06-16 | أجسام مضادة (أنتي – بي دي – 1) وطريقة الإنتاج وطريقة استخدام كل منهم |
| MX2018014937A MX2018014937A (es) | 2016-07-13 | 2017-07-04 | Anticuerpos anti-pd-1, un metodo de produccion y un metodo para su uso. |
| NZ750221A NZ750221A (en) | 2016-07-13 | 2017-07-04 | Anti-pd-1 antibodies, method for producing same and method for using same |
| PE2019000027A PE20190450A1 (es) | 2016-07-13 | 2017-07-04 | Anticuerpos anti-pd-1, un metodo de produccion y un metodo para su uso |
| CN201780055794.3A CN110023335B (zh) | 2016-07-13 | 2017-07-04 | 抗-pd-1抗体、其生产方法及其使用方法 |
| JP2018567611A JP6993992B2 (ja) | 2016-07-13 | 2017-07-04 | 抗ｐｄ－１抗体、その産生方法及びその使用方法 |
| EP17828049.1A EP3486257A4 (en) | 2016-07-13 | 2017-07-04 | ANTI-PD-1 ANTIBODY, METHOD FOR PRODUCING THE SAME AND METHOD FOR USE THEREOF |
| MA44547A MA44547B1 (fr) | 2016-07-13 | 2017-07-04 | Anticorps anti-pd-1,procédé de leur production et de leur utilisation |
| AU2017297138A AU2017297138B2 (en) | 2016-07-13 | 2017-07-04 | Anti-PD-1 antibodies, method for producing same and method for using same |
| US16/095,800 US11136408B2 (en) | 2016-07-13 | 2017-07-04 | Anti-PD-1 antibodies, method for producing same and method for using same |
| CA3021372A CA3021372A1 (en) | 2016-07-13 | 2017-07-04 | Anti-pd-1 antibodies, a method of production and a method of use thereof |
| CR20190009A CR20190009A (es) | 2016-07-13 | 2017-07-04 | Anticuerpos anti-pd-1, un método de producción y un método para su uso. |
| BR112019000436A BR112019000436A2 (pt) | 2016-07-13 | 2017-07-04 | anticorpos anti-pd-1, método de produção e método de uso dos mesmos |
| KR1020197003862A KR102482710B1 (ko) | 2016-07-13 | 2017-07-04 | 항-pd-1 항체, 이의 생산 방법 및 사용 방법 |
| PCT/RU2017/050056 WO2018013017A1 (ru) | 2016-07-13 | 2017-07-04 | Анти-pd-1-антитела, способ их получения и способ применения |
| PH12018550179A PH12018550179A1 (en) | 2016-07-13 | 2018-10-26 | Anti-pd-1 antibodies, method for producing same and method for using same |
| CL2018003407A CL2018003407A1 (es) | 2016-07-13 | 2018-11-29 | Anticuerdos anti-pd-1, método para producir el mismo y método para usar el mismo. |
| NI201900002A NI201900002A (es) | 2016-07-13 | 2019-01-08 | Anticuerpos anti-pd-1, un método de producción y un método para su uso |
| ZA2019/00792A ZA201900792B (en) | 2016-07-13 | 2019-02-07 | Anti-pd-1 antibodies, method for producing same and method for using same |
| CONC2019/0001246A CO2019001246A2 (es) | 2016-07-13 | 2019-02-12 | Anticuerpos anti-pd-1, un método de producción y un método para su uso |
| ECSENADI201910852A ECSP19010852A (es) | 2016-07-13 | 2019-02-13 | Anticuerpos anti-pd-1, un método de producción y un método para su uso |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016128487A RU2656181C1 (ru) | 2016-07-13 | 2016-07-13 | Анти-pd-1-антитела, способ их получения и способ применения |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2016128487A3 true RU2016128487A3 (enExample) | 2018-01-18 |
| RU2656181C1 RU2656181C1 (ru) | 2018-05-31 |
Family
ID=60953256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016128487A RU2656181C1 (ru) | 2016-07-13 | 2016-07-13 | Анти-pd-1-антитела, способ их получения и способ применения |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11136408B2 (enExample) |
| EP (1) | EP3486257A4 (enExample) |
| JP (1) | JP6993992B2 (enExample) |
| KR (1) | KR102482710B1 (enExample) |
| CN (1) | CN110023335B (enExample) |
| BR (1) | BR112019000436A2 (enExample) |
| CA (1) | CA3021372A1 (enExample) |
| CL (1) | CL2018003407A1 (enExample) |
| CO (1) | CO2019001246A2 (enExample) |
| CR (1) | CR20190009A (enExample) |
| EC (1) | ECSP19010852A (enExample) |
| JO (1) | JOP20190002A1 (enExample) |
| MA (1) | MA44547B1 (enExample) |
| MX (1) | MX2018014937A (enExample) |
| NI (1) | NI201900002A (enExample) |
| NZ (1) | NZ750221A (enExample) |
| PE (1) | PE20190450A1 (enExample) |
| PH (1) | PH12018550179A1 (enExample) |
| RU (1) | RU2656181C1 (enExample) |
| WO (1) | WO2018013017A1 (enExample) |
| ZA (1) | ZA201900792B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300122A (en) | 2015-11-18 | 2023-03-01 | Merck Sharp ַ& Dohme Llc | Substances that bind to PD1 and/or LAG3 |
| JP7275030B2 (ja) | 2017-01-20 | 2023-05-17 | タユー ファシャ バイオテック メディカル グループ カンパニー， リミテッド | 抗ｐｄ－１抗体およびその使用 |
| BR112019021520A2 (pt) | 2017-04-14 | 2020-08-04 | Tollnine, Inc. | oligonucleotídeo, composto, polinucleotídeo imunomodulador, composição, conjugado, método para modular um receptor, método de tratamento de um tumor, método de tratamento de câncer, método para tratar um tumor, método de prevenção de câncer, método para induzir uma resposta imune |
| US10995149B2 (en) | 2017-06-05 | 2021-05-04 | Janssen Biotech, Inc. | Antibodies that specifically bind PD-1 and methods of use |
| CN118126157A (zh) | 2017-08-03 | 2024-06-04 | 美国安进公司 | 白介素-21突变蛋白和治疗方法 |
| MX2020007291A (es) | 2018-01-12 | 2020-09-10 | Amgen Inc | Anticuerpos anti-pd-1 y metodos de tratamiento. |
| WO2019148410A1 (en) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1 antibodies |
| EP3823991A4 (en) * | 2018-07-19 | 2022-08-03 | Tayu Huaxia Biotech Medical Group Co., Ltd. | ANTI-PD-1 ANTIBODIES, DOSAGE FORMS AND USES THEREOF |
| CN109652453B (zh) * | 2018-12-29 | 2021-04-06 | 杭州科兴生物科技有限公司 | 一种基于pd-1/pdl-1阻断功能及生物效应的抗癌药物快速筛选方法 |
| US20220241412A1 (en) | 2019-05-24 | 2022-08-04 | Pfizer Inc. | Combination therapies using cdk inhibitors |
| JP7680967B2 (ja) * | 2019-06-14 | 2025-05-21 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | Ｐｄ－１に対する抗体およびその使用方法 |
| TWI844666B (zh) | 2019-08-22 | 2024-06-11 | 俄羅斯聯邦商拜奧卡德聯合股份公司 | 抗ＰＤ－１抗體Ｐｒｏｌｇｏｌｉｍａｂ的水性藥物組合物及其用途 |
| RU2753282C2 (ru) * | 2019-09-19 | 2021-08-12 | Закрытое Акционерное Общество "Биокад" | ИММУНОЦИТОКИН, ВКЛЮЧАЮЩИЙ ГЕТЕРОДИМЕРНЫЙ БЕЛКОВЫЙ КОМПЛЕКС НА ОСНОВЕ IL-15/IL-15Rα, И ЕГО ПРИМЕНЕНИЕ |
| IL295759A (en) | 2020-02-28 | 2022-10-01 | Tallac Therapeutics Inc | Transglutaminase mediated coupling |
| CA3181776A1 (en) | 2020-05-26 | 2021-12-02 | Boehringer Ingelheim International Gmbh | Anti-pd-1 antibodies |
| US20220168293A1 (en) | 2020-12-02 | 2022-06-02 | Pfizer Inc. | Time to resolution of axitinib-related adverse events |
| US20250270320A1 (en) * | 2020-12-10 | 2025-08-28 | Eutilex Co., Ltd. | Anti-pd-1 antibody and uses thereof |
| PE20241732A1 (es) | 2021-03-31 | 2024-08-19 | Merus Nv | Dominios de union a pd-1 novedosos |
| MA62924A1 (fr) | 2021-04-08 | 2024-03-29 | Biocad Joint Stock Co | Traitement de néoplasies malignes à l'aide d'une combinaison d'anticorps anti-pd-1 |
| TW202327595A (zh) | 2021-10-05 | 2023-07-16 | 美商輝瑞大藥廠 | 用於治療癌症之氮雜內醯胺化合物的組合 |
| WO2023079428A1 (en) | 2021-11-03 | 2023-05-11 | Pfizer Inc. | Combination therapies using tlr7/8 agonist |
| CN116925223A (zh) * | 2022-04-02 | 2023-10-24 | 普米斯生物技术(珠海)有限公司 | 抗pd-1单克隆抗体及其衍生物和用途 |
| EP4598960A1 (en) * | 2022-10-05 | 2025-08-13 | Chulalongkorn University | Monoclonal antibodies against human programmed cell death protein 1 (pd-1) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3530736A3 (en) * | 2005-05-09 | 2019-11-06 | ONO Pharmaceutical Co., Ltd. | Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| PT2170959E (pt) * | 2007-06-18 | 2014-01-07 | Merck Sharp & Dohme | Anticorpos para o receptor humano de morte programada pd-1 |
| US8062852B2 (en) * | 2007-10-01 | 2011-11-22 | The Children's Hospital And Regional Medical Center | Detection and treatment of autoimmune disorders |
| EP3279215B1 (en) * | 2009-11-24 | 2020-02-12 | MedImmune Limited | Targeted binding agents against b7-h1 |
| CN102892786B (zh) * | 2010-03-11 | 2016-03-16 | Ucb医药有限公司 | Pd-1抗体 |
| TW201134488A (en) * | 2010-03-11 | 2011-10-16 | Ucb Pharma Sa | PD-1 antibodies |
| LT2691417T (lt) * | 2011-03-29 | 2018-10-25 | Roche Glycart Ag | Antikūno fc variantai |
| RS61400B1 (sr) * | 2013-05-02 | 2021-02-26 | Anaptysbio Inc | Antitela usmerena protiv programirane smrti-1 (pd-1) |
| SMT202300039T1 (it) * | 2013-09-13 | 2023-03-17 | Beigene Switzerland Gmbh | Anticorpi anti-pd1 e loro uso come terapia e per diagnostica |
| EP3177640B1 (en) * | 2014-08-08 | 2020-05-06 | The Board of Trustees of the Leland Stanford Junior University | High affinity pd-1 agents and methods of use |
| GB201419084D0 (en) | 2014-10-27 | 2014-12-10 | Agency Science Tech & Res | Anti-PD-1 antibodies |
| TWI595006B (zh) * | 2014-12-09 | 2017-08-11 | 禮納特神經系統科學公司 | 抗ｐｄ－１抗體類和使用彼等之方法 |
-
2016
- 2016-07-13 RU RU2016128487A patent/RU2656181C1/ru active
-
2017
- 2017-06-16 JO JOP/2019/0002A patent/JOP20190002A1/ar unknown
- 2017-07-04 CA CA3021372A patent/CA3021372A1/en active Pending
- 2017-07-04 NZ NZ750221A patent/NZ750221A/en unknown
- 2017-07-04 MA MA44547A patent/MA44547B1/fr unknown
- 2017-07-04 BR BR112019000436A patent/BR112019000436A2/pt unknown
- 2017-07-04 PE PE2019000027A patent/PE20190450A1/es unknown
- 2017-07-04 EP EP17828049.1A patent/EP3486257A4/en active Pending
- 2017-07-04 US US16/095,800 patent/US11136408B2/en active Active
- 2017-07-04 MX MX2018014937A patent/MX2018014937A/es unknown
- 2017-07-04 CR CR20190009A patent/CR20190009A/es unknown
- 2017-07-04 CN CN201780055794.3A patent/CN110023335B/zh active Active
- 2017-07-04 WO PCT/RU2017/050056 patent/WO2018013017A1/ru not_active Ceased
- 2017-07-04 KR KR1020197003862A patent/KR102482710B1/ko active Active
- 2017-07-04 JP JP2018567611A patent/JP6993992B2/ja active Active
-
2018
- 2018-10-26 PH PH12018550179A patent/PH12018550179A1/en unknown
- 2018-11-29 CL CL2018003407A patent/CL2018003407A1/es unknown
-
2019
- 2019-01-08 NI NI201900002A patent/NI201900002A/es unknown
- 2019-02-07 ZA ZA2019/00792A patent/ZA201900792B/en unknown
- 2019-02-12 CO CONC2019/0001246A patent/CO2019001246A2/es unknown
- 2019-02-13 EC ECSENADI201910852A patent/ECSP19010852A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT524874A5 (enExample) | ||
| AT524834A2 (enExample) | ||
| AU2018438767B1 (enExample) | ||
| AT521543A3 (enExample) | ||
| AT524961A5 (enExample) | ||
| BR102019026286B1 (pt) | Método e aparelho para o avanço de produtos a serem moldados | |
| BR102019025884B1 (pt) | Sistema de segurança aprimorado para máquinas de operação de autopropulsão | |
| BR102019023514B1 (pt) | Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna | |
| BR112021001434B1 (pt) | Aço com alto teor de manganês e método de produção do mesmo | |
| BR112021001374B1 (pt) | Composição farmacêutica para o tratamento da hipertensão e seu uso | |
| BR112021001128B1 (pt) | Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit | |
| BR112021001186B1 (pt) | Aparelho para o tratamento de celulite para tratar expressões de celulite na pele de um paciente associadas a um local de tratamento de septos | |
| BR112021000922B1 (pt) | Tela de filtro, e, método para purificar água de alimentação | |
| BR112020023832B1 (pt) | Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral | |
| BR112020024987B1 (pt) | Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico | |
| BR112020023823B1 (pt) | Distribuidor | |
| BR112020022482B1 (pt) | Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico | |
| BR112020022658B1 (pt) | Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido | |
| BR112020022516B1 (pt) | Processo para degomagem enzimática de óleo | |
| BR112020021042B1 (pt) | Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas | |
| BR112020020812B1 (pt) | Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado | |
| BR122025016281B1 (pt) | Cassetes de manuseio de fluido | |
| BR112020015757B1 (pt) | Métodos, sistema, kit e dispositivos para visualização e remoção de tumor | |
| BR102019000241B1 (pt) | Veículo modular, configurável, sobre plataforma de chassis comum, e métodos e sistemas associados | |
| BR102018073077B1 (pt) | Processo de extração de gelatina de resíduos de couro curtido ao cromo wet blue |